Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05197413 · ClinicalTrials.gov registry record · NA

Study to Evaluate the Efficacy of Arrae's Bloat & Calm Alchemy Capsules to Reduce Bloating, Heartburn and Gas, and Alleviate the Intensity of IBS Symptoms

A NA study of Anxiety and IBS - Irritable Bowel Syndrome, sponsored by Arrae.

Completed
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT05197413 is a NA study of Anxiety and IBS - Irritable Bowel Syndrome that has completed, run by Arrae. The registered enrollment target is 35 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05197413, a NA study of Anxiety and IBS - Irritable Bowel Syndrome, has completed, sponsored by Arrae.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

This is an open-label observational crossover trial to study the efficacy of a commercial dietary supplement and its effect on common symptoms of IBS (such as bloating, gas, heartburn, and other symptoms).

Interventions

  • DIETARY_SUPPLEMENT Arrae bloat supplement

Study Locations (1)

California

  • Citruslabs - Santa Monica

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2021-09-01
Est. Completion 2021-12-31
Phase NA

Sponsor

Arrae

2 total trials

What the Registry Record Tells You About NCT05197413

The ClinicalTrials.gov registry entry for NCT05197413 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (92% lower). The listed sponsor is Arrae, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Arrae bloat supplement is the first listed.

NCT05197413 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05197413 about?

NCT05197413 is a clinical study titled "Study to Evaluate the Efficacy of Arrae's Bloat & Calm Alchemy Capsules to Reduce Bloating, Heartburn and Gas, and Alleviate the Intensity of IBS Symptoms". This is an open-label observational crossover trial to study the efficacy of a commercial dietary supplement and its effect on common symptoms of IBS (such as bloating, gas, heartburn, and other symptoms).

What is the current status of trial NCT05197413?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2021-09-01. Estimated completion is 2021-12-31.

What conditions does trial NCT05197413 study?

This clinical trial studies the following conditions: Anxiety, IBS - Irritable Bowel Syndrome.

What interventions are being tested in trial NCT05197413?

The interventions under investigation include: Arrae bloat supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05197413?

This trial is sponsored by Arrae, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05197413 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.